180 related articles for article (PubMed ID: 25436211)
1. Mechanisms of blood flow and hypoxia production in rat 9L-epigastric tumors.
Koch CJ; Jenkins WT; Jenkins KW; Yang XY; Shuman AL; Pickup S; Riehl CR; Paudyal R; Poptani H; Evans SM
Tumor Microenviron Ther; 2013 Jan; 1():1-13. PubMed ID: 25436211
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode.
Jenkins WT; Evans SM; Koch CJ
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):1005-17. PubMed ID: 10705024
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5.
Ziemer LS; Evans SM; Kachur AV; Shuman AL; Cardi CA; Jenkins WT; Karp JS; Alavi A; Dolbier WR; Koch CJ
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):259-66. PubMed ID: 12552344
[TBL] [Abstract][Full Text] [Related]
4. Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors.
Evans SM; Jenkins KW; Jenkins WT; Dilling T; Judy KD; Schrlau A; Judkins A; Hahn SM; Koch CJ
Radiat Res; 2008 Dec; 170(6):677-90. PubMed ID: 19138031
[TBL] [Abstract][Full Text] [Related]
5. Distribution of misonidazole adducts in 9L gliosarcoma tumors and spheroids: implications for oxygen distribution.
Franko AJ; Koch CJ; Boisvert DP
Cancer Res; 1992 Jul; 52(14):3831-7. PubMed ID: 1617656
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status.
Evans SM; Jenkins WT; Shapiro M; Koch CJ
Adv Exp Med Biol; 1997; 411():215-25. PubMed ID: 9269430
[TBL] [Abstract][Full Text] [Related]
7. Quantification of longitudinal tissue pO2 gradients in window chamber tumours: impact on tumour hypoxia.
Dewhirst MW; Ong ET; Braun RD; Smith B; Klitzman B; Evans SM; Wilson D
Br J Cancer; 1999 Apr; 79(11-12):1717-22. PubMed ID: 10206282
[TBL] [Abstract][Full Text] [Related]
8. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide].
Evans SM; Joiner B; Jenkins WT; Laughlin KM; Lord EM; Koch CJ
Br J Cancer; 1995 Oct; 72(4):875-82. PubMed ID: 7547234
[TBL] [Abstract][Full Text] [Related]
9. Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding.
Evans SM; Judy KD; Dunphy I; Jenkins WT; Nelson PT; Collins R; Wileyto EP; Jenkins K; Hahn SM; Stevens CW; Judkins AR; Phillips P; Geoerger B; Koch CJ
Cancer Res; 2004 Mar; 64(5):1886-92. PubMed ID: 14996753
[TBL] [Abstract][Full Text] [Related]
10. Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).
Yuan H; Schroeder T; Bowsher JE; Hedlund LW; Wong T; Dewhirst MW
J Nucl Med; 2006 Jun; 47(6):989-98. PubMed ID: 16741309
[TBL] [Abstract][Full Text] [Related]
11. Oxygenation of the rat 9L gliosarcoma and the rat 13672 mammary carcinoma with various doses of a hemoglobin solution.
Teicher BA; Holden SA; Dupuis NP; Kusomoto T; Liu M; Liu F; Menon K
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):827-33. PubMed ID: 7994406
[TBL] [Abstract][Full Text] [Related]
12. A Two-Component Assay for Hypoxia Incorporating Long-Term Nitroreduction and Short-Term DNA-Damage Allows Differentiation of the Three Hypoxia Sub-types.
Koch CJ
Radiat Res; 2018 Jul; 190(1):72-87. PubMed ID: 29746214
[TBL] [Abstract][Full Text] [Related]
13. 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors.
Evans SM; Jenkins WT; Joiner B; Lord EM; Koch CJ
Cancer Res; 1996 Jan; 56(2):405-11. PubMed ID: 8542599
[TBL] [Abstract][Full Text] [Related]
14. Blood oxygenation level dependent, blood volume, and blood flow responses to carbogen and hypoxic hypoxia in 9L rat gliomas as measured by MRI.
Jerome NP; Hekmatyar SK; Kauppinen RA
J Magn Reson Imaging; 2014 Jan; 39(1):110-9. PubMed ID: 23553891
[TBL] [Abstract][Full Text] [Related]
15. The radiation response of cells from 9L gliosarcoma tumours is correlated with [F18]-EF5 uptake.
Koch CJ; Shuman AL; Jenkins WT; Kachur AV; Karp JS; Freifelder R; Dolbier WR; Evans SM
Int J Radiat Biol; 2009 Dec; 85(12):1137-47. PubMed ID: 19995239
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor.
Bouchet A; Bidart M; Miladi I; Le Clec'h C; Serduc R; Coutton C; Regnard P; Khalil E; Dufort S; Lemasson B; Laissue J; Pelletier L; Le Duc G
Tumour Biol; 2014 Jul; 35(7):6221-33. PubMed ID: 24633919
[TBL] [Abstract][Full Text] [Related]
17. 31P magnetic resonance spectroscopy is sensitive to tumor hypoxia: perfusion and oxygenation of rat 9L gliosarcoma after treatment with BCNU.
Steen RG; Graham MM
NMR Biomed; 1991 Jun; 4(3):117-24. PubMed ID: 1911098
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Hypoxia PET Tracer (18)F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models.
Chitneni SK; Bida GT; Zalutsky MR; Dewhirst MW
J Nucl Med; 2014 Jul; 55(7):1192-7. PubMed ID: 24854792
[TBL] [Abstract][Full Text] [Related]
19. Use of power Doppler ultrasound-guided biopsies to locate regions of tumour hypoxia.
Evans SM; Laughlin KM; Pugh CR; Sehgal CM; Saunders HM
Br J Cancer; 1997; 76(10):1308-14. PubMed ID: 9374376
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia in human intraperitoneal and extremity sarcomas.
Evans SM; Hahn SM; Magarelli DP; Zhang PJ; Jenkins WT; Fraker DL; Hsi RA; McKenna WG; Koch CJ
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):587-96. PubMed ID: 11173159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
